VANGUARD GROUP INC - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Zentalis Pharmaceuticals Inc (ZNTL)

Filing Manager: VANGUARD GROUP INC
Reporting Manager: The Vanguard Group
Security: Zentalis Pharmaceuticals Inc Common Stock
Symbol: ZNTL
Shares outstanding: 71.3M shares
Disclosed Ownership: 3.27M shares
Ownership: 4.59%
Form type: SCHEDULE 13G/A
Date filed: 1/31/2025, 10:09 AM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
The Vanguard Group	4.59%	3.27M	0	25.1K	Ashley Grim	Head of Global Fund Administration